Dr. Lee is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1000 Brabham Ave
# 509
Jacksonville, NC 28546Phone+1 240-340-1658Fax+1 301-295-1299
Summary
- Dr. Tida Lee is an Infectious Disease specialist based in Jacksonville, NC, and graduated from the Uniformed Services University of the Health Sciences in 2009. She has co-authored several publications on topics such as gonococcal and chlamydial infections in the military, vaccine safety and immunogenicity, and COVID-19. Her work has been cited multiple times, indicating its relevance to the field. Dr. Lee has also been involved in clinical trials focused on gut health during travel and developing vaccines for enterotoxigenic Escherichia coli.
Education & Training
Uniformed Services University of the Health Sciences F. Edward Hebert School of MedicineClass of 2009
Certifications & Licensure
NC State Medical License 2022 - 2025
VA State Medical License 2009 - 2024
DC State Medical License 2014 - 2014
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Infectious Disease
Clinical Trials
- Dose Escalating Study of a Prototype CS6 Subunit Vaccine With a Modified Heat-labile Enterotoxin From Enterotoxigenic Escherichia Coli (ETEC) Start of enrollment: 2018 Jan 16
- Trial to Evaluate Dietary Supplements to Maintain Gut Health During Travel Start of enrollment: 2022 May 27
Publications & Presentations
PubMed
- 26 citationsSafety and immunogenicity of intramuscularly administered CS6 subunit vaccine with a modified heat-labile enterotoxin from enterotoxigenic Escherichia coli.Tida Lee, Ramiro L. Gutierrez, Milton Maciel, Steven T. Poole, Kayla J. Testa
Vaccine. 2021-08-18 - 22 citationsThe SARS-CoV-2 mRNA vaccine breakthrough infection phenotype includes significant symptoms, live virus shedding, and viral genetic diversity.Simon Pollett, Stephanie A Richard, Anthony C. Fries, Mark P Simons, Katrin Mende
Clinical Infectious Diseases. 2021-06-12 - 10 citationsSARS-CoV-2 Infections and Serologic Responses Among Military Personnel Deployed on the USNS COMFORT to New York City During the COVID-19 pandemicTahaniyat Lalani, Tida K Lee, Eric D Laing, Andrew Ritter, Elizabeth Cooper
Open Forum Infectious Diseases. 2021-01-23
Press Mentions
U.S. Government Buys COVID-19 Antibody Cocktail Discovered at VUMCApril 6th, 2021- Naval Medical Center Portsmouth Helping Lead International Study on Antibodies to Fight COVID-19March 23rd, 2021
- Naval Medical Center Portsmouth Conducts Clinical Trial for Prevention of COVID-19March 16th, 2021
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
